Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -6.16% is 45% above its 5-year average of -11.25%, around the middle of its 5-year range (-21.03%–4.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.46% above its 12-month average of -13.82%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.16%.
RETURN ON EQUITY (ROE)
-6.16%
RETURN ON EQUITY (ROE) AVG TTM
-13.82%
RETURN ON EQUITY (ROE) AVG 3Y
-12.67%
RETURN ON EQUITY (ROE) AVG 5Y
-11.25%
RETURN ON EQUITY (ROE) AVG 10Y
-9.99%
RETURN ON EQUITY (ROE) AVG 15Y
-10.88%
RETURN ON EQUITY (ROE) AVG 20Y
-10.97%
CURRENT VS TTM AVG
+55.46%
CURRENT VS 3Y AVG
+51.41%
CURRENT VS 5Y AVG
+45.30%
CURRENT VS 10Y AVG
+38.41%
CURRENT VS 15Y AVG
+43.45%
CURRENT VS 20Y AVG
+43.88%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+85.35%
vs the sector median at left
OPKO Health, Inc.
Market Cap
$1.09B
Return on Equity (ROE)
-6.16%
TTM Avg
-13.82%
3Y Avg
-12.67%
5Y Avg
-11.25%
Market Cap
$1.09B
Return on Equity (ROE)
-39.54%
TTM Avg
-24.09%
3Y Avg
36.77%
5Y Avg
36.77%
Market Cap
$1.08B
Return on Equity (ROE)
22.66%
TTM Avg
22.95%
3Y Avg
21.85%
5Y Avg
17.09%
Market Cap
$1.10B
Return on Equity (ROE)
-57.77%
TTM Avg
-49.78%
3Y Avg
-41.82%
5Y Avg
-41.82%
Market Cap
$1.10B
Return on Equity (ROE)
1.05%
TTM Avg
-23.37%
3Y Avg
-7.64%
5Y Avg
-0.10%
Market Cap
$1.11B
Return on Equity (ROE)
-48.56%
TTM Avg
-84.22%
3Y Avg
-65.23%
5Y Avg
-44.45%
Market Cap
$1.11B
Return on Equity (ROE)
-281.14%
TTM Avg
-124.20%
3Y Avg
-84.35%
5Y Avg
-63.72%
Market Cap
$1.13B
Return on Equity (ROE)
N/A
TTM Avg
35.70%
3Y Avg
35.70%
5Y Avg
35.70%
Market Cap
$1.05B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OPKO Health, Inc. (OPK) | $1.09B | -6.16% | -13.82% | -12.67% | -11.25% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -39.54% | -24.09% | 36.77% | 36.77% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 22.66% | 22.95% | 21.85% | 17.09% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | -57.77% | -49.78% | -41.82% | -41.82% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 1.05% | -23.37% | -7.64% | -0.10% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -48.56% | -84.22% | -65.23% | -44.45% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | -281.14% | -124.20% | -84.35% | -63.72% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | 35.70% | 35.70% | 35.70% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.54% | -40.81% | -170.75% | -114.78% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -244.91% | -17.45% | -30.16% | -48.76% |
ROE
-6.2%
ROA
-4.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -6.16% |
| 2026-03-31 | -17.68% |
| 2025-12-31 | -17.80% |
| 2025-09-30 | -13.82% |
| 2025-06-30 | -13.66% |
| 2025-03-31 | -2.97% |
| 2024-12-31 | -3.90% |
| 2024-09-30 | -9.53% |
| 2024-06-30 | -17.42% |
| 2024-03-31 | -20.15% |
| 2023-12-31 | -13.59% |
| 2023-09-30 | -14.37% |
| 2023-06-30 | -13.63% |
| 2023-03-31 | -18.77% |
| 2022-12-31 | -21.03% |
| 2022-09-30 | -19.46% |
| 2022-06-30 | -11.76% |
| 2022-03-31 | -7.22% |
| 2021-12-31 | -1.79% |
| 2021-09-30 | 4.30% |
| 2021-06-30 | 4.07% |
| 2021-03-31 | 7.12% |
| 2020-12-31 | 1.83% |
| 2020-09-30 | -7.02% |
| 2020-06-30 | -12.58% |
| 2020-03-31 | -18.94% |
| 2019-12-31 | -19.50% |
| 2019-09-30 | -16.97% |
| 2019-06-30 | -14.30% |
| 2019-03-31 | -10.82% |
| 2018-12-31 | -8.54% |
| 2018-09-30 | -16.26% |
| 2018-06-30 | -17.10% |
| 2018-03-31 | -17.60% |
| 2017-12-31 | -16.75% |
| 2017-09-30 | -5.20% |
| 2017-06-30 | -3.66% |
| 2017-03-31 | -2.09% |
| 2016-12-31 | -1.20% |
| 2016-09-30 | -0.47% |
| 2016-06-30 | 6.62% |
| 2016-03-31 | 3.76% |
| 2015-12-31 | -1.52% |
| 2015-09-30 | -4.29% |
| 2015-06-30 | -31.33% |
| 2015-03-31 | -29.79% |
| 2014-12-31 | -20.54% |
| 2014-09-30 | -15.17% |
| 2014-06-30 | -16.01% |
| 2014-03-31 | -14.94% |
| 2013-12-31 | -13.05% |
| 2013-09-30 | -11.27% |
| 2013-06-30 | -15.20% |
| 2013-03-31 | -17.04% |
| 2012-12-31 | -14.26% |
| 2012-09-30 | -6.90% |
| 2012-06-30 | -5.74% |
| 2012-03-31 | -2.70% |
| 2011-12-31 | -0.80% |
| 2011-09-30 | -19.87% |
| 2011-06-30 | -17.52% |
| 2011-03-31 | -16.14% |
| 2010-12-31 | -82.10% |
| 2010-09-30 | -135.79% |
| 2010-06-30 | -52.62% |
| 2010-03-31 | -46.30% |
| 2009-12-31 | -52.26% |
| 2009-09-30 | -47.92% |
| 2009-06-30 | -84.31% |
| 2008-09-30 | -435.30% |
| 2008-03-31 | -333.48% |
| 2005-12-31 | -2.12% |
| 2005-09-30 | -1.55% |
| 2005-06-30 | -15.02% |
| 2005-03-31 | -15.63% |
| 2004-12-31 | -19.59% |
| 2004-09-30 | -34.74% |
| 2004-06-30 | -45.72% |
| 2004-03-31 | -57.46% |
| 2003-12-31 | -56.22% |
| 2003-09-30 | -70.67% |
| 2003-06-30 | -71.26% |
